Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine receptor D2L is a G protein-coupled receptor and one of two major isoforms produced by alternative splicing of the DRD2 gene. Predominantly postsynaptic, D2L modulates motor activity, cognition, and emotion. As the main target for antipsychotic medications, it plays a key role in treating schizophrenia and other dopamine-related disorders. Dysfunction or genetic variation within D2L contributes to diseases such as Parkinson’s disease and addiction.
Antagonism or agonism at the D2L receptor to modulate dopaminergic signaling
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor D2 Long Isoform (D2L).